Latest Bioprocessing Podcast Episodes
Topical Ocular Biologics with Claris Bio's Clarke Atwell
Business Of Biotech - July 01, 2024 10:00 - 58 minutesWe love to hear from our listeners. Send us a message. Built on the back of hepatocyte growth factor discoveries by Harvard Drs. Reza Dana and Sunil Chauhan, ClarisBio is rewriting the ophthalmology rulebook. CEO Clark Atwell acknowledges that it's not the first to bring topically-administered...
C&G Regulatory Guidance with Lineage Therapeutics' Brian Culley
Business Of Biotech - June 24, 2024 10:00 - 1 hourWe love to hear from our listeners. Send us a message. When we last caught up with Brian Culley, CEO at Lineage Cell Therapeutics, it was January, 2021. A pandemic was raging. His company was moving mountains to keep its OpRegen dry AMD clinical trial together, and did so despite lockdowns tha...
True DEI Value in Biopharma with Arcellx's Rami Elghandour
Business Of Biotech - June 17, 2024 10:00 - 1 hourWe love to hear from our listeners. Send us a message. The cell therapy company Arcellx has, by any and every measure, been outperforming its peers. Its stock has rallied on the back of the strong performance of its multiple myeloma candidate, and the promise of its AML, MDS, and solid tumor p...
Mission-Driven Dementia Funding with DDF's Jonathan Behr
Business Of Biotech - June 10, 2024 10:00 - 55 minutesWe love to hear from our listeners. Send us a message. If there's anyone qualified to analyze an early-stage therapeutic technology and place bets with other people's money, it's scientist-turned-venture capitalist Jonathan Behr, Ph.D. He built a distinguished venture capital career on the ba...
ADCs Ignited with Daiichi Sankyo Inc.'s Ken Keller
Business Of Biotech - June 03, 2024 10:00 - 1 hourWe love to hear from our listeners. Send us a message. Just a few years ago, Daiichi Sankyo wasn't considered a player in the oncology therapeutics space, and it certainly wasn't a player in ADCs. But then, just a few years ago, who was? Fast forward to 2023, and we see an ADC arena that drove...
ADCs Ignited with Daiichi Sankyo's Ken Keller
Business Of Biotech - June 03, 2024 10:00 - 1 hourWe love to hear from our listeners. Send us a message. Just a few years ago, Daiichi Sankyo wasn't considered a player in the oncology therapeutics space, and it certainly wasn't a player in ADCs. But then, just a few years ago, who was? Fast forward to 2023, and we see an ADC arena that drove...
Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D.
Business Of Biotech - May 27, 2024 10:00 - 56 minutesWe love to hear from our listeners. Send us a message. Mythic Therapeutics Chief Scientific Officer and co-founder Brian Fiske, Ph.D. broke some unwritten protocol with his rapid and multifaceted transition from academia to industry. He calls his many, and sometimes concurrent, early experienc...
The Anti-CDMO with CTMC's Jason Bock, Ph.D. and KSQ's Thomas Leitch
Business Of Biotech - May 20, 2024 10:00 - 57 minutesWe love to hear from our listeners. Send us a message. This isn't your typical drug sponsor + CDMO story. In fact, CTMC's Jason Bock, Ph.D. says you shouldn't even classify his company a CDMO. He's not wrong. While some of the company's services aren't dissimilar from those offered by a contra...
A New Prescription For PBMs with Allan Shaw
Business Of Biotech - May 13, 2024 10:00 - 40 minutesWe love to hear from our listeners. Send us a message. Back by popular demand, biopharma industry opinionator extraordinaire Allan Shaw rejoins the Business of Biotech to expose the murky role Pharmacy Benefit Managers (PBMs) play in the last, costly mile of the drug distribution supply chain....
New Apps For AI in mRNA With Anima Biotech's Yochi Slonim
Business Of Biotech - May 06, 2024 10:00 - 59 minutesWe love to hear from our listeners. Send us a message. From San Francisco’s Silicon Valley to Tel Aviv’s Silicon Wadi, software business entrepreneur Yochi Slonim made a name for himself in global tech hubs around the globe. Notably, he was co-founder of billion-dollar Mercury Interactive, whi...
Circular RNA with Orna Therapeutics' Tom Barnes, Ph.D. and Advancing RNA's Anna Rose Welch
Business Of Biotech - April 29, 2024 10:00 - 59 minutesWe love to hear from our listeners. Send us a message. As if Orna Therapeutics' CEO Thomas Barnes, CEO isn't a enough to draw you in to the Business of Biotech, we teamed up with Advancing RNA Editorial & Community Director Anna Rose Welch to co-host this week's episode. Together, Anna Rose an...
Physician + Biotech Builder with Tome Biosciences' Rahul Kakkar, M.D.
Business Of Biotech - April 22, 2024 10:00 - 1 hourWe love to hear from our listeners. Send us a message. Novel technologies aren’t interesting to Rahul Kakkar, M.D. unless they help patients. Sounds rational, but it’s actually a unique perspective in a platform-crazed biotech industry. Dr. Kakkar’s worldview is shaped by his work as a physici...
Commercial Readiness with ImmunityBio's Bobby Reddy, M.D.
Business Of Biotech - April 15, 2024 10:00 - 56 minutesWe love to hear from our listeners. Send us a message. This episode of the Business of Biotech begins with a personal story about my dad and the standard of care in bladder cancer, before shifting to the work that Dr. Bobby Reddy and his team at ImmunityBio are doing to change that standard of...
Precision Drug Delivery with Ampersand Biomedicines' Jason Gardner, D.Phil.
Business Of Biotech - April 08, 2024 10:00 - 49 minutesWe love to hear from our listeners. Send us a message. Ampersand Biomedicines CEO Jason Gardner, D.Phil. first took the leap from a global pharmaceutical giant to a startup at the forefront of transplant medicine innovation. Since that time, he's seen most of the ups and the downs that come wi...
Funding Alzheimer's Tx Dev with ADDF's Karen Harris
Business Of Biotech - April 01, 2024 10:00 - 40 minutesWe love to hear from our listeners. Send us a message. We've really been looking forward to dropping this episode with Karen Harris, Chief Financial Officer and Head of Mission-Related Investing at the Alzheimer's Drug Discovery Foundation. While the markets have warmed a bit since we recorded...
The AI Impact with Generate:Biomedicines' Mike Nally
Business Of Biotech - March 25, 2024 10:00 - 1 hourWe love to hear from our listeners. Send us a message. Few drug discovery and development concepts are as hyped, and as such, draw as much polarity from drug developers, as machine learning and artifical intelligence. One company on the bullish end of the spectrum is Flagship Pioneering's Gene...
Strategic Deals with CinRx's Gavin Samuels, M.D.
Business Of Biotech - March 18, 2024 10:00 - 47 minutesWe love to hear from our listeners. Send us a message. Gavin Samuels, M.D. found his work as an intensive care physician boring. After earning his M.D., he did that for a few years before moving into intensive care management roles. It wasn't until he left the hospital and entered biopharma th...
Serial Success With Triumvira's Rob Williamson
Business Of Biotech - March 11, 2024 12:00 - 31 minutesWe love to hear from our listeners. Send us a message. Rob Williamson's mind and hands have shaped more than 20 biotech startups, leading some to IPO and landing others firmly in Big Bio through acquisition by companies like Merck. Hanging around as many successful exits as Williamson has seen...
The Innovator's Dilemma with Lumen Bioscience's Brian Finrow, J.D.
Business Of Biotech - March 04, 2024 11:00 - 50 minutesWe love to hear from our listeners. Send us a message. In biotech, when "one of these things doesn't look like the other one," it can be a blessing or a curse. On one hand, scientific novelty is praised and rewarded. On the other, unfamiliarity breeds skepticism from the investment community. ...
Precision Radiopharmaceuticals with Ratio's Jack Hoppin, Ph.D.
Business Of Biotech - February 26, 2024 11:00 - 40 minutesWe love to hear from our listeners. Send us a message. Multimodal approaches to the delivery of radiologically active compounds have created a fertile environment to for players in the space to put on a precision medicine clinic, so to speak. What’s more, Radiopharmaceuticals create a unique b...
Managing Mergers With Sail Biomedicines' Guillaume Pfefer, Ph.D.
Business Of Biotech - February 19, 2024 11:00 - 51 minutesWe love to hear from our listeners. Send us a message. While you might be aware that Sail Biomedicines was just formed up in Q4 of last year, the product of Flagship Pioneering’s decision to merge Senda Biosciences and Laronde, two of its programmable medicine platform companies. What you lik...
Reprogramming Human Cells With bit.bio's Mark Kotter, M.D.
Business Of Biotech - February 12, 2024 11:00 - 45 minutesWe love to hear from our listeners. Send us a message. The concept of programmable biology is fueling a new breed of biotech, one that requires the marriage of computational and traditional science (and both computational and traditional scientists) on the entire journey from discovery to comm...
Inhalable mRNA with Ethris' Carsten Rudolph, Ph.D.
Business Of Biotech - February 05, 2024 11:00 - 46 minutesWe love to hear from our listeners. Send us a message. Without doubt, the grand and collaborative experiment that was the mRNA COVID vaccine contributed mightily to the pandemic response and continues to save lives untold. It also demonstrated the collective power of public/private partnership...
Biotech Is Back with Allan Shaw
Business Of Biotech - January 29, 2024 11:00 - 51 minutesWe love to hear from our listeners. Send us a message. The Business of Biotech took a trip to San Francisco for the JP Morgan Healthcare Conference, that most target-richest of environments for those of us who like talking shop with biotech builders. The results of that trip will feed the next...
Multimodal R&D Management with Incyte's Jim Lee, M.D., Ph.D.
Business Of Biotech - January 22, 2024 11:00 - 50 minutesWe love to hear from our listeners. Send us a message. Success at multimodal, multi-indication, deep-pipelined Incyte—where commercial operations are as familiar as pre-discovery activity is—begins at the earliest opportunity to achieve research and discovery efficiencies. The company’s a bit ...
Building A Biotech Hub with Intellia Therapeutics' John Leonard, M.D.
Business Of Biotech - January 15, 2024 11:00 - 55 minutesWe love to hear from our listeners. Send us a message. We spend a lot of time talking with our guests about building biotech companies. That’s true of this episode too, but today we’re taking a step further with John Leonard, M.D., longtime CEO at Intellia Therapeutics. In addition to how he’s...
Art Of The Pivot with Elevation Oncology's Joe Ferra
Business Of Biotech - January 08, 2024 11:00 - 49 minutesWe love to hear from our listeners. Send us a message. Relatively new CEO Joseph Ferra has orchestrated some pretty significant change at Elevation Oncology in the two(ish) years since the Business of Biotech last hosted the company. In that short time, Ferra advance from CFO to CEO, a move t...
CDMO Collab with Scorpius BioManufacturing's Steve Lavezoli + Fina Biosolutions' Dr. Andrew Lees
Business Of Biotech - January 01, 2024 11:00 - 51 minutesWe love to hear from our listeners. Send us a message. A new year marks a fresh start for biotech partnerships, and to kick off 2024, we're highlighting a good one. Fina Biosolutions' Dr. Andrew Lees recently signed on with Scorpius BioManufacturing to support his company's growth plan. On tod...
Biotech Down Under with BiomeBank's Dr. Sam Costello
Business Of Biotech - December 25, 2023 11:00 - 1 hourWe love to hear from our listeners. Send us a message. Merry Christmas, Business of Biotechers! On this Christmas Day release, we’re taking a trip to the land down under to visit with Dr. Sam Costello, a former gastroenterologist-turned managing director and co-founder at Adelaide, Australia-b...
IL-2 Program Profits with Bonum's Drs. John Mulligan and Neela Patel
Business Of Biotech - December 18, 2023 11:00 - 1 hourWe love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, we welcome two extraordinary guests - Dr. Neela Patel, a molecular biologist-turned-Chief Business Officer, and Dr. John Mulligan, an academic-turned-founder of newly-formed Bonum Therapeu...
Related Bioprocessing Topics
- Biotech 2